Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo

• Main Authors: Dai, Z.-J, Ma, X.-B, Kang, H.-F, Gao, J, Min, W.-L, Guan, H.-T, Diao, Y, Lu, W.-F, Wang, X.-J
• Other Authors: MECHANICAL ENGINEERING
• Format: Article
• Published: 2020
• Subjects: antineoplastic agent; celecoxib; cyclooxygenase 2; dimethylbenz[a]anthracene; tamoxifen; animal experiment; antineoplastic activity; article; breast cancer; cancer incidence; cancer inhibition; cell cycle; cell cycle G0 phase; cell cycle S phase; cell proliferation; controlled study; down regulation; enzyme linked immunosorbent assay; flow cytometry; human; human cell; in vitro study; in vivo culture; nonhuman; protein expression; rat; real time polymerase chain reaction
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181588
• Institution: National University of Singapore

10.1186/1475-2867-12-53